Christopher R. Fenimore, SVP Finance & CFO: Regeneron Pharmaceuticals REGN Sell · Filed 24/08/29

Trade details

Type: Insider sale
Amount: $2,694,936.27
Shares · price: 2,237 sh · $1,204.71 a share
Held after: 1,378 sh
Stock: Regeneron Pharmaceuticals REGN
Person: Christopher R. FenimoreSVP Finance & CFO
Trade date: 24/08/28
Filed: 24/08/29
Days to filing: 1 days

Sold 61.9% of holdings

Share of holding sold: 61.9%

Regeneron Pharmaceuticals trades, last 26 weeks

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/07/29~24/09/27

Christopher R. Fenimore's recent trades

Christopher R. FenimoreSVP Finance & CFO
SellRegeneron Pharmaceuticals
Sell
Regeneron Pharmaceuticals
REGN
$1.1M
928 sh
$1.1M
Filed 24/08/29
Traded 24/08/28
Christopher R. FenimoreSVP Finance & CFO
SellRegeneron Pharmaceuticals
Sell
Regeneron Pharmaceuticals
REGN
$923.4K
766 sh
$923.4K
Filed 24/08/29
Traded 24/08/28
Christopher R. FenimoreSVP Finance & CFO
SellRegeneron Pharmaceuticals
Sell
Regeneron Pharmaceuticals
REGN
$542.8K
450 sh
$542.8K
Filed 24/08/29
Traded 24/08/28
Christopher R. FenimoreSVP Finance & CFO
SellRegeneron Pharmaceuticals
Sell
Regeneron Pharmaceuticals
REGN
$284.5K
236 sh
$284.5K
Filed 24/08/29
Traded 24/08/28
Christopher R. FenimoreSVP Finance & CFO
SellRegeneron Pharmaceuticals
Sell
Regeneron Pharmaceuticals
REGN
$283.3K
235 sh
$283.3K
Filed 24/08/29
Traded 24/08/28